Status:
COMPLETED
Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation
Lead Sponsor:
University Hospital Ostrava
Conditions:
Mitral Valve Disease
Coronary Artery Disease
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The aim of our study was to investigate, whether enhancement of left atrial cryoablation by ablation of the autonomic nervous system of left atrium leads to influencing the outcomes of surgical treatm...
Detailed Description
The observed patient file consisted of 100 patients, who have undergone a combined open-heart surgery at our department between July 2012 and December 2014. The patients were indicated for the surgica...
Eligibility Criteria
Inclusion
- Indication for open-heart surgery (mitral valve disease and/or tricuspidal valve disease and/or aortic valve disease and/or coronary artery disease and/or other)
- Concomitant paroxysmal, persistent, long standing persistent atrial fibrillation
- Signing of the informed consent
Exclusion
- Age below 40 and over 80 years of age
- Left ventricular ejection fraction below 25%
- Left atrium diameter over 60mm
- Permanent atrial fibrillation
- Polymorbidity (Euroscore II over 10)
- Emergency surgery
- Renal insufficiency (creatinine over 200 umol/l)
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03239262
Start Date
July 1 2012
End Date
February 28 2016
Last Update
August 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.